---
title: Insights on R Package Quality and Validation for Clinical Trials
date: '2023-09-06'
linkTitle: https://www.r-bloggers.com/2023/09/insights-on-r-package-quality-and-validation-for-clinical-trials/
source: R-bloggers
description: |-
  <div style = "width:60%; display: inline-block; float:left; ">
  Moving away from proprietary languages, Roche has made a notable decision to freeze their legacy macros library. With great enthusiasm, they now embrace R as the primary framework for evidence generation in late-stage clinical trials, and they remain open to exploring additional open-source languages in this evolving landscape. James Black, ...</div>
  <div style = "width: 40%; display: inline-block; float:right;"></div>
  <div style="clear: both;"></div>
  <strong>Continue reading</strong>: <a href="https://www.r-bloggers.com/2023/09/insig ...
disable_comments: true
---
<div style = "width:60%; display: inline-block; float:left; ">
Moving away from proprietary languages, Roche has made a notable decision to freeze their legacy macros library. With great enthusiasm, they now embrace R as the primary framework for evidence generation in late-stage clinical trials, and they remain open to exploring additional open-source languages in this evolving landscape. James Black, ...</div>
<div style = "width: 40%; display: inline-block; float:right;"></div>
<div style="clear: both;"></div>
<strong>Continue reading</strong>: <a href="https://www.r-bloggers.com/2023/09/insig ...